Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07684053
Recruiting
Digital Screening for Atrial Fibrillation to Prevent Stroke
Not applicable · Austria · 1 site
Registry update: 6 Jul 2026
NCT07463963
Recruiting
Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract Infections Prevention: a Non-inferiority Randomized Controlled Trial
Not applicable · France · 15 sites
Registry update: 4 Sept 2026
NCT07452224
Recruiting
ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer
Phase 2 · United States · 2 sites
Registry update: 10 Jul 2026
2025-520587-18-00
Recruiting
SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults with Focal Onset Seizures
Phase 2 · Bulgaria, Hungary, Poland · 18 sites
Registry update: 2 Sept 2026
NCT07658560
Recruiting
A Study to Evaluate Efficacy and Safety of BGM0504 Tablets in Overweight or Obese Participants Without Diabetes
Phase 2 · China · 1 site
Registry update: 15 Oct 2026
NCT07581509
Recruiting
Pharmacokinetics, Safety, and Immunogenicity of Bmab1800 and Keytruda® as Adjuvant Monotherapy in Patients With Melanoma
Phase 1 · Brazil · 1 site
Registry update: 2 Oct 2026
NCT07643766
Recruiting
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Phase 2 · United States · 9 sites
Registry update: 6 Aug 2026
NCT07666490
Recruiting
BETRI-Prospective: Asthma Control in Single Inhaler ICS/LABA/LAMA (87/5/9 pMDI [BDP/FF/GB - 100/6/12.5 μg]) vs Single Inhaler ICS/LABA (200/6 pMDI [BDP/FF - 200/6 μg])
Phase 4 · Bulgaria, Germany, Spain, France, Georgia, Italy, Poland, Romania, Slovakia · 89 sites
Registry update: 31 Jul 2026
NCT06741072
Recruiting
BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants
Phase 1 · United States · 1 site
Registry update: 2 Jul 2026
NCT07764978
Recruiting
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Phase 3 · Australia, Brazil, Canada, Germany, Denmark, Spain, France, United Kingdom, Italy, Japan, South Korea, Poland, Sweden, Taiwan, United States · 110 sites
Registry update: 14 Aug 2026
NCT07604766
Recruiting
An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in China
Phase 3 · China · 17 sites
Registry update: 3 Nov 2026
NCT07686016
Recruiting
Prostate Radiotherapy and Metastasis-Directed Therapy in Synchronous Oligometastatic Prostate Cancer
Not applicable · Poland · 1 site
Registry update: 6 Jul 2026
NCT07546981
Recruiting
Efficacy and Safety of CHF 5993 100/6/12.5 μg HFA-152a pMDI in Patients With Asthma Uncontrolled on Medium Doses of Inhaled Corticosteroids in Combination With Long-acting ß2-agonists
Phase 3 · China · 1 site
Registry update: 8 Jul 2026
NCT06607783
Recruiting
PRostate Cancer Enhanced Diagnosis by Calibration Technology
Not applicable · United Kingdom · 1 site
Registry update: 9 Sept 2026
NCT07677800
Recruiting
Impact of Overweight, Obesity, and Lifestyle Changes on Work Performance and Well-Being in Medical Residents
Not applicable · Italy · 1 site
Registry update: 8 Sept 2026
NCT07665983
Recruiting
The Bottle Optimization Testing Tiny Little Eaters Study
Not applicable · United States · 1 site
Registry update: 1 Jul 2026
NCT07724756
Recruiting
Phase II Study of QLC2519 in Pediatric Solid Tumor Participants
Phase 2 · China · 1 site
Registry update: 24 Jul 2026
NCT07749170
Recruiting
FORWARD: Functional Outcomes in Real-World Treatment And Revascularization of Non-dominant and Distal M2 Occlusions
Not applicable · United States · 7 sites
Registry update: 29 Oct 2026
NCT07284602
Recruiting
Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
Phase 3 · Belgium, Canada, Czechia, Germany, Denmark, Spain, France, Greece, Italy, Netherlands, Poland, Portugal, Romania, United States · 91 sites
Registry update: 23 Oct 2026
NCT07539155
Recruiting
Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer
Phase 1/2 · United States · 1 site
Registry update: 1 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.